Back to Search Start Over

What do the Universal Test and Treat Trials tell us about the path to HIV epidemic control?

Authors :
Sarah Fidler
Richard J. Hayes
Joseph Larmarange
Diane V. Havlir
François Dabis
Moses R. Kamya
Sian Floyd
Tendani Gaolathe
Janet Moore
Shahin Lockman
Gabriel Chamie
Collins Iwuji
Helen Ayles
Maya L. Petersen
National Institutes of Health
University of California (UC)
Botswana Harvard AIDS Institute Partnership
Harvard School of Public Health
London School of Hygiene and Tropical Medicine (LSHTM)
Zambart
Centre population et développement (CEPED - UMR_D 196)
Institut de Recherche pour le Développement (IRD)-Université Paris Cité (UPCité)
Santé, vulnérabilités et relations de genre au sud (SAGESUD - ERL Inserm U1244)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre population et développement (CEPED - UMR_D 196)
Institut de Recherche pour le Développement (IRD)-Université Paris Cité (UPCité)-Institut de Recherche pour le Développement (IRD)-Université Paris Cité (UPCité)
Brighton and Sussex Medical School (BSMS)
Imperial College London
Makerere University [Kampala, Ouganda] (MAK)
University of California [Berkeley] (UC Berkeley)
Bordeaux population health (BPH)
Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
President's Emergency Plan for AIDS Relief, Gilead Sciences, Bill and Melinda Gates Foundation
French National Agency for Research on AIDS and Viral Hepatitis
Deutsche Gesellschaft fur Internationale Zusammenarbeit
Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)
School of Public Health
Source :
Journal of the International AIDS Society, Journal of the International AIDS Society, 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩, Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩
Publication Year :
2020
Publisher :
Wiley, 2020.

Abstract

Author(s): Havlir, Diane; Lockman, Shahin; Ayles, Helen; Larmarange, Joseph; Chamie, Gabriel; Gaolathe, Tendani; Iwuji, Collins; Fidler, Sarah; Kamya, Moses; Floyd, Sian; Moore, Janet; Hayes, Richard; Petersen, Maya; Dabis, Francois; (Universal Test, Treat Trials) UT3 Consortium | Abstract: IntroductionAchieving HIV epidemic control globally will require new strategies to accelerate reductions in HIV incidence and mortality. Universal test and treat (UTT) was evaluated in four randomized population-based trials (BCPP/Ya Tsie, HPTN 071/PopART, SEARCH, ANRS 12249/TasP) conducted in sub-Saharan African(SSA) during expanded antiretroviral treatment (ART) eligibility by World Health Organization guidelines and the UNAIDS 90-90-90 campaign.DiscussionThese three-year studies were conducted in Botswana, Zambia, Uganda, Kenya and South Africa in settings with baseline HIV prevalence from 4% to 30%. Key observations across studies were: (1) Universal testing (implemented via a variety of home and community-based testing approaches) achieved g90% coverage in all studies. (2) When coupled with robust linkage to HIV care, rapid ART start and patient-centred care, UTT achieved among the highest reported population levels of viral suppression in SSA. Significant gains in population-level viral suppression were made in regions with both low and high baseline population viral load; however, viral suppression gains were not uniform across all sub-populations and were lower among youth. (3) UTT resulted innmarked reductions in community HIV incidence when universal testing and robust linkage were present. However, HIV elimination targets were not reached. In BCPP and HPTN 071, annualized HIV incidence was approximately 20% to 30% lower in the intervention (which included universal testing) compared to control arms (no universal testing). In SEARCH (where both arms had universal testing), incidence declined 32% over three years. (4) UTT reduced HIV associated mortality by 23% in the intervention versus control communities in SEARCH, a study in whichnmortality was comprehensively measured.ConclusionsThese trials provide strong evidence that UTT inclusive of universal testing increases population-level viral suppression and decreases HIV incidence and mortality faster than the status quo in SSA and should be adapted at a sub-country level as a public health strategy. However, more is needed, including integration of new prevention interventions into UTT, in order to reach UNAIDS HIV elimination targets.

Details

Language :
English
ISSN :
17582652
Database :
OpenAIRE
Journal :
Journal of the International AIDS Society, Journal of the International AIDS Society, 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩, Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2020, Journal of the International AIDS Society, 23 (2), ⟨10.1002/jia2.25455⟩
Accession number :
edsair.doi.dedup.....b74a5abbfa71ced4976c1c74dc8fbc1d
Full Text :
https://doi.org/10.1002/jia2.25455⟩